Notizie Reviva Pharmaceuticals - RVPH

Ultime notizie

Data	Ora	Fonte	Titolo
16/2/2024	22:32	EDGAR2	Form SC 13D/A - General statement of acquisition of..
14/2/2024	06:15	EDGAR2	Form EFFECT - Notice of Effectiveness
13/2/2024	23:00	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
02/2/2024	22:38	EDGAR2	Form S-3 - Registration statement under Securities Act of..
17/11/2023	22:05	EDGAR2	Form 8-K - Current report
17/11/2023	22:03	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
14/11/2023	22:12	EDGAR2	Form 8-K - Current report
30/10/2023	13:20	EDGAR2	Form 8-K - Current report
04/10/2023	23:03	EDGAR2	Form DEF 14A - Other definitive proxy statements
04/10/2023	23:02	EDGAR2	Form 8-K - Current report
17/8/2023	12:30	EDGAR2	Form 8-K - Current report
14/8/2023	22:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/2023	22:15	EDGAR2	Form 8-K - Current report
24/7/2023	22:16	EDGAR2	Form 8-K - Current report

Apertura: 2,96	Min: 2,80	Max: 3,0515
Chiusura: 2,94